EMBRYONIC DEVELOPMENT & STEM CELL COMPENDIUM
Content
All Cell Therapies > Cell Therapy Card
Sign in for full access

Autologous bone marrow-derived mesenchymal stem cells for treatment of heart muscle damage

This study aims to determine the safety and feasibility of direct intra-myocardial injection of autologous bone marrow mesenchymal stem cells (BM-MSCs) in adult subjects undergoing coronary artery bypass graft (CABG) or transmyocardial revascularization (TMR).
See additional Cell Therapies for: Heart
Autologous bone marrow-derived mesenchymal stem cells for treatment of heart muscle damage